Evidence map›Paper›PMID 23774230›Full record

ArticleHypertension (Dallas, Tex. : 1979)2013

Role of Axl in early kidney inflammation and progression of salt-dependent hypertension.

Sri N Batchu, Angie Hughson, Janice Gerloff, Deborah J Fowell, Vyacheslav A Korshunov

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Natriuretic Peptide Receptor 2 Locus Contributes to Carotid Remodeling.Journal of the American Heart Association · 2020
    Article
  5. Article
  6. TAM receptors in cardiovascular disease.Cardiovascular research · 2019
    Review
  7. Article
  8. Vitamin K Dependent Proteins in Kidney Disease.International journal of molecular sciences · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.Arteriosclerosis, thrombosis, and vascular biology · 2016
    Article
  14. Article
  15. Axl modulates immune activation of smooth muscle cells in vein graft remodeling.American journal of physiology. Heart and circulatory physiology · 2015
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sri N BatchuDepartment of Medicine and Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Angie Hughson
Janice Gerloff
Deborah J Fowell
Vyacheslav A Korshunov
University of Rochester · US

Funding

Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue SiteR01AI072690 · NIAID · UNIVERSITY OF ROCHESTER · PI FOWELL, DEBORAH J · 2008 to 2020
$3.6M
Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue SiteR37AI072690 · NIAID · CORNELL UNIVERSITY · PI Deborah J Fowell · 2023 to 2026
$1.9M
The Role of Immune Response in Vascular Dysfunction in HypertensionR01HL105623 · NHLBI · UNIVERSITY OF ROCHESTER · PI KORSHUNOV, VYACHESLAV A · 2011 to 2015
$1.5M
NHLBI NIH HHS HL105623NHLBI NIH HHS R01 HL105623NIAID NIH HHS R01 AI072690NIAID NIH HHS R37 AI072690
6 · The paper itself

Abstract

The Gas6/Axl pathway regulates many cell functions and is implicated in hypertension. In this study, we aimed to investigate the role of Axl in immune cells on initiation and progression of salt-dependent hypertension. Deoxycorticosterone acetate (75 mg/60 days release)-salt hypertension was induced for 1 week or 6 weeks in Axl chimeras generated by bone marrow transplant to restrict Axl deficiency to hematopoietic or nonhematopoietic compartments. Depletion of Axl in hematopoietic cells (Axl(-/-) →Axl(+/+)) reduced (133 ± 2 mm Hg) increase in systolic blood pressure compared with other Axl chimeras (≈150 mm Hg) 1 week after deoxycorticosterone acetate-salt. Urine protein and renal oxidative stress were lowest in Axl(-/-) →Axl(+/+) at 1 week after deoxycorticosterone acetate-salt. Compensatory increase in Gas6 in kidneys of recipient Axl(-/-) may affect kidney function and blood pressure in early phase of hypertension. Flow cytometry on kidneys from Axl(-/-) →Axl(+/+) showed increase in total leukocytes, B, and dendritic cells and decrease in macrophages compared with Axl(+/+) →Axl(+/+). These immune changes were associated with decrease in proinflammatory gene expression, in particular interferon γ. Systolic blood pressure returned to baseline in Axl(-/-) →Axl(+/+) and Axl(-/-) →Axl(-/-) but remained increased in Axl(+/+) →Axl(+/+) and Axl(+/+) →Axl(-/-) chimeras after 6 weeks of deoxycorticosterone acetate-salt. Vascular apoptosis was increased in the global Axl(-/-) chimeras in the late phase of hypertension. In summary, we found that expression of Axl in hematopoietic cells is critical for kidney pathology in early phase of salt-dependent hypertension. However, Axl in both hematopoietic and nonhematopoietic lineages contributes to the late phase of hypertension.

Indexed as

AnimalsAxl Receptor Tyrosine KinaseCell MovementChemokinesCytokinesDesoxycorticosteroneDisease ProgressionGrowth Arrest-Specific Protein 6HypertensionIntercellular Signaling Peptides and ProteinsKidneyLeukocytesMaleMiceNephritisProto-Oncogene ProteinsAxl Receptor Tyrosine KinaseAXL receptor tyrosine kinase, mouseChemokinesCytokinesDesoxycorticosteroneGrowth Arrest-Specific Protein 6Intercellular Signaling Peptides and ProteinsProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesAxl receptor tyrosine kinasebone marrow transplantationhypertensionimmunitykidney

Identifiers

PMID23774230
PMCPMC3822523
OpenAlexW2162735519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.